Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PROK
- Price
- 0.66
- Stock movement up
- +0.04 (1.75%)
- Company name
- ProKidney Corp.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 313.19M
- Ent value
- 236.42M
- Price/Sales
- 69.69
- Price/Book
- 0.71
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -3.33%
- 3 year return
- -32.73%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PROK does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 69.69 |
| Price to Book | 0.71 |
| EV to Sales | 52.61 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 134.99M |
| EPS (TTM) | -0.40 |
| FCF per share (TTM) | -1.05 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.49M |
| Gross profit (TTM) | 1.67M |
| Operating income (TTM) | -156.31M |
| Net income (TTM) | -50.84M |
| EPS (TTM) | -0.40 |
| EPS (1y forward) | -0.59 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 37.09% |
| Operating margin (TTM) | -3478.30% |
| Profit margin (TTM) | -1131.33% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 108.09M |
| Net receivables | 5.10M |
| Total current assets | 430.23M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 55.14M |
| Total assets | 474.79M |
| Accounts payable | 2.85M |
| Short/Current long term debt | 6.44M |
| Total current liabilities | 25.18M |
| Total liabilities | 31.32M |
| Shareholder's equity | 443.47M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -127.56M |
| Capital expenditures (TTM) | 4.76M |
| Free cash flow (TTM) | -132.33M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -11.46% |
| Return on Assets | -10.71% |
| Return on Invested Capital | -11.44% |
| Cash Return on Invested Capital | -29.77% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.27 |
| Daily high | 2.35 |
| Daily low | 2.22 |
| Daily Volume | 888K |
| All-time high | 13.78 |
| 1y analyst estimate | 5.83 |
| Beta | 1.81 |
| EPS (TTM) | -0.40 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 18 Nov 2025 |
Downside potential
Loading...
Downside potential data
| PROK | S&P500 | |
| Current price drop from All-time high | -83.16% | -1.46% |
| Highest price drop | -96.29% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -60.30% | -10.99% |
| Avg time to new high | 87 days | 12 days |
| Max time to new high | 614 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
313.19M
Marketcap category
Small-cap
Description
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Employees
204
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page